Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Viyash Scientific acquires BioForLife Italia

PRIVATESep 08, 2026about 3 hours ago

Acquiring Company

Viyash Scientific Limited

Acquired Company

BioForLife Italia S.r.l

HyderabadMilanBiotechnologyHealth Care

Description

Viyash Scientific Limited has obtained Italian regulatory approval for its acquisition of BioForLife Italia S.r.l. The transaction involves Viyash's subsidiary, Alivira Animal Health Limited, acquiring 100% of the shares. The deal is expected to close within two months following the approval announcement. This acquisition marks a significant milestone for Viyash Scientific in the biotechnology sector.

Company Information

Company

Viyash Scientific Limited

Location

Hyderabad, Telangana, India

About

Viyash Scientific Limited is a global player focused on the life sciences industry. The company specializes in innovative solutions and products. It is dedicated to advancing health and well-being through scientific research and development. Viyash Scientific operates in various international markets.

Don't miss Viyash Scientific Limited's next move

Get an email the moment Viyash Scientific Limited makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Srinivas
Senior decision-maker at this company
••••••••@••••••••

See Srinivas's verified email →

Ramakant
Senior decision-maker at this company
••••••••@••••••••

See Ramakant's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Viyash Scientific Limited's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired BioForLife Italia S.r.l?

BioForLife Italia S.r.l was acquired by Viyash Scientific Limited, based in Hyderabad. The deal was reported on September 8, 2026. Viyash Scientific Limited is a global player focused on the life sciences industry. The company specializes in innovative solutions and products. Viyash Scientific Limited is privately held.

When did Viyash Scientific Limited acquire BioForLife Italia S.r.l?

Viyash Scientific Limited's acquisition of BioForLife Italia S.r.l was reported on September 8, 2026. Viyash Scientific Limited has obtained Italian regulatory approval for its acquisition of BioForLife Italia S.r.l. The transaction involves Viyash's subsidiary, Alivira Animal Health Limited, acquiring 100% of the shares. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does BioForLife Italia S.r.l do?

BioForLife Italia S.r.l. is a company engaged in the biotechnology sector. It focuses on developing life-enhancing biological products. The company aims to support health industries with innovative biotechnological solutions. It is privately held, operating in Biotechnology, and is based in Milan.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.